« Previous
Next »
Titles
- Paying for drugs in Medicare Part D under current law and under proposals to redesign the program1
- Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates1
- Prescription drugs and Medicare Part D: a report on access, satisfaction, and cost1
- Prescription drugs in Nebraska: a survey of experiences and opinions1
- Prescription drugs: spending, use, and prices1
